Request Sample Inquiry
Contraceptive Drugs Market

Contraceptive Drugs Market

Contraceptive Drugs Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:


Base Year:



Jun - 2022



Report Code:


Segments Covered
  • By Product By Product Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives
  • By Age Group By Age Group 15–24 Years, 25–34 Years, 35–44 Years, Above 44 Years
  • By  End User By End User Homecare, Hospitals, Clinics
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 12.62 Billion
Revenue 2030Revenue 2030: USD 18.94 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 5.20%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Research Methodology: Contraceptive Drugs Market by Product by Age Group by End User by Region - Global Market Assessment, 2021 - 2028

Secondary Research

Primary Research:

The later stage covers data validation and collection from primary research. The information gained/procured from the secondary data sources is validated through extensive primary interviews with industry experts across the Contraceptive Drugs supply chain. The primary research is also conducted to identify key players in the market and to gather and validate already procured information pertaining to their market-specific financial information. Moreover, primary research is used to gain/validate information about:

  • Contraceptive Drugs market size at regional and country level
  • Key industry players and their market share and Contraceptive Drugs market-specific sales/revenue
  • Understanding of the Contraceptive Drugs supply chain and overall ecosystem

Data Triangulation and Market Size Estimations

After arriving at the global market numbers, top-down and bottom-up approaches are used to estimate, validate and finalize the market size of the Contraceptive Drugs market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. During the data triangulation process, the data was analyzed by employing various data models and statistical techniques to arrive at exact statistics and market size for each segment/sub-segment of the market.  The data is analyzed and triangulated by considering all the key market impacting factors from both supply and demand side of Contraceptive Drugs market. 

In terms of revenue, the Global Contraceptive Drugs Market is expected to reach USD 16.5 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 5.4% from 2022 to 2028. The increasing awareness about birth control, government initiatives, and increased use of oral pills are anticipa...
Frequently Asked Question
  • The global Contraceptive Drugs valued at USD 12.62 Billion in 2022 and is expected to reach USD 18.94 Billion in 2030 growing at a CAGR of 5.20%.

  • The prominent players in the market are Agile Therapeutics, Allergan PLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Piramal Healthcare, Mylan N.V., Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd..

  • The market is project to grow at a CAGR of 5.20% between 2023 and 2030.

  • The driving factors of the Contraceptive Drugs include

    • Rise in need for preventing unwanted pregnancy

  • North America was the leading regional segment of the Contraceptive Drugs in 2022.

Related Reports